Reconstruction of the superior vena cava: Benefits of postoperative surveillance and secondary endovascular interventions

Y. S. Alimi, P. Gloviczki, Terri J Vrtiska, P. C. Pairolero, L. G. Canton, T. C. Bower, S. Harmsen, Jr Hallett, Jr Cherry, A. W. Stanson, L. H. Hollier, J. D. Gruss, G. P. Clagett, L. R. Pickard

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Purpose: Superior vena cava (svc) reconstructions are rarely performed; therefore the need for surveillance and the results of secondary interventions are unknown. Methods: During a 14-year period 19 patients (11 male, 8 female; mean age 41.9 years, range 8 to 69 years) underwent SVC reconstruction for symptomatic nonmalignant disease. Causes included mediastinal fibrosis (n = 12), indwelling foreign bodies (n = 4), idiopathic thrombosis (n = 2), and antithrombin III deficiency (n = 1). Spiral saphenous vein graft (n = 14), polytetrafluoroethylene (n = 4), or human allograft (n = 1) was implanted. Results: No early death or pulmonary embolism occurred. Four early graft stenoses or thromboses (spiral saphenous vein graft, n = 2, polytetrafluoroethylene n = 2) required thrombectomy, with success in three. During a mean follow-up of 49.5 months (range, 4.7 to 137 months), 95 imaging studies were performed (average, five per patient; range, one to 10 studies). Venography detected mild or moderate graft stenosis in seven patients; two progressed to severe stenosis. Two additional grafts developed early into severe stenosis. Four of 19 grafts occluded during follow-up (two polytetrafluoroethylene, two spiral saphenous vein graft). Computed tomography failed to identify stenosis in two grafts, magnetic resonance imaging failed to confirm one stenosis and one graft occlusion, and duplex scanning was inconclusive on graft patency in 10 patients. Angioplasty was performed in all four patients with severe stenosis, with simultaneous placement of Wallstents in two. One of the Wallstents occluded at 9 months. Repeat percutaneous transluminal angioplasty was necessary in two patients, with placement of Palmaz stents in one. Only one graft occlusion and one severe graft stenosis occurred beyond I year. The primary, primary-assisted, and secondary patency rates were 61%, 78%, and 83% at I year and 53%, 70%, and 74% at 5 years, respectively. Conclusion: Long-term secondary patency rates justify SVC grafting for benign disease. Postoperative surveillance with contrast venography is indicated in the first year to detect graft problems. Endovascular techniques may salvage and improve the patency of SVC grafts.

Original languageEnglish (US)
Pages (from-to)287-301
Number of pages15
JournalJournal of Vascular Surgery
Volume27
Issue number2
DOIs
StatePublished - 1998

Fingerprint

Superior Vena Cava
Transplants
Pathologic Constriction
Saphenous Vein
Polytetrafluoroethylene
Phlebography
Angioplasty
Thrombosis
Antithrombin III Deficiency
Thrombectomy
Endovascular Procedures
Foreign Bodies
Pulmonary Embolism
Stents
Allografts

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Reconstruction of the superior vena cava : Benefits of postoperative surveillance and secondary endovascular interventions. / Alimi, Y. S.; Gloviczki, P.; Vrtiska, Terri J; Pairolero, P. C.; Canton, L. G.; Bower, T. C.; Harmsen, S.; Hallett, Jr; Cherry, Jr; Stanson, A. W.; Hollier, L. H.; Gruss, J. D.; Clagett, G. P.; Pickard, L. R.

In: Journal of Vascular Surgery, Vol. 27, No. 2, 1998, p. 287-301.

Research output: Contribution to journalArticle

Alimi, YS, Gloviczki, P, Vrtiska, TJ, Pairolero, PC, Canton, LG, Bower, TC, Harmsen, S, Hallett, J, Cherry, J, Stanson, AW, Hollier, LH, Gruss, JD, Clagett, GP & Pickard, LR 1998, 'Reconstruction of the superior vena cava: Benefits of postoperative surveillance and secondary endovascular interventions', Journal of Vascular Surgery, vol. 27, no. 2, pp. 287-301. https://doi.org/10.1016/S0741-5214(98)70359-3
Alimi, Y. S. ; Gloviczki, P. ; Vrtiska, Terri J ; Pairolero, P. C. ; Canton, L. G. ; Bower, T. C. ; Harmsen, S. ; Hallett, Jr ; Cherry, Jr ; Stanson, A. W. ; Hollier, L. H. ; Gruss, J. D. ; Clagett, G. P. ; Pickard, L. R. / Reconstruction of the superior vena cava : Benefits of postoperative surveillance and secondary endovascular interventions. In: Journal of Vascular Surgery. 1998 ; Vol. 27, No. 2. pp. 287-301.
@article{858bf0bfe6074365bc84f0f1036643e4,
title = "Reconstruction of the superior vena cava: Benefits of postoperative surveillance and secondary endovascular interventions",
abstract = "Purpose: Superior vena cava (svc) reconstructions are rarely performed; therefore the need for surveillance and the results of secondary interventions are unknown. Methods: During a 14-year period 19 patients (11 male, 8 female; mean age 41.9 years, range 8 to 69 years) underwent SVC reconstruction for symptomatic nonmalignant disease. Causes included mediastinal fibrosis (n = 12), indwelling foreign bodies (n = 4), idiopathic thrombosis (n = 2), and antithrombin III deficiency (n = 1). Spiral saphenous vein graft (n = 14), polytetrafluoroethylene (n = 4), or human allograft (n = 1) was implanted. Results: No early death or pulmonary embolism occurred. Four early graft stenoses or thromboses (spiral saphenous vein graft, n = 2, polytetrafluoroethylene n = 2) required thrombectomy, with success in three. During a mean follow-up of 49.5 months (range, 4.7 to 137 months), 95 imaging studies were performed (average, five per patient; range, one to 10 studies). Venography detected mild or moderate graft stenosis in seven patients; two progressed to severe stenosis. Two additional grafts developed early into severe stenosis. Four of 19 grafts occluded during follow-up (two polytetrafluoroethylene, two spiral saphenous vein graft). Computed tomography failed to identify stenosis in two grafts, magnetic resonance imaging failed to confirm one stenosis and one graft occlusion, and duplex scanning was inconclusive on graft patency in 10 patients. Angioplasty was performed in all four patients with severe stenosis, with simultaneous placement of Wallstents in two. One of the Wallstents occluded at 9 months. Repeat percutaneous transluminal angioplasty was necessary in two patients, with placement of Palmaz stents in one. Only one graft occlusion and one severe graft stenosis occurred beyond I year. The primary, primary-assisted, and secondary patency rates were 61{\%}, 78{\%}, and 83{\%} at I year and 53{\%}, 70{\%}, and 74{\%} at 5 years, respectively. Conclusion: Long-term secondary patency rates justify SVC grafting for benign disease. Postoperative surveillance with contrast venography is indicated in the first year to detect graft problems. Endovascular techniques may salvage and improve the patency of SVC grafts.",
author = "Alimi, {Y. S.} and P. Gloviczki and Vrtiska, {Terri J} and Pairolero, {P. C.} and Canton, {L. G.} and Bower, {T. C.} and S. Harmsen and Jr Hallett and Jr Cherry and Stanson, {A. W.} and Hollier, {L. H.} and Gruss, {J. D.} and Clagett, {G. P.} and Pickard, {L. R.}",
year = "1998",
doi = "10.1016/S0741-5214(98)70359-3",
language = "English (US)",
volume = "27",
pages = "287--301",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Reconstruction of the superior vena cava

T2 - Benefits of postoperative surveillance and secondary endovascular interventions

AU - Alimi, Y. S.

AU - Gloviczki, P.

AU - Vrtiska, Terri J

AU - Pairolero, P. C.

AU - Canton, L. G.

AU - Bower, T. C.

AU - Harmsen, S.

AU - Hallett, Jr

AU - Cherry, Jr

AU - Stanson, A. W.

AU - Hollier, L. H.

AU - Gruss, J. D.

AU - Clagett, G. P.

AU - Pickard, L. R.

PY - 1998

Y1 - 1998

N2 - Purpose: Superior vena cava (svc) reconstructions are rarely performed; therefore the need for surveillance and the results of secondary interventions are unknown. Methods: During a 14-year period 19 patients (11 male, 8 female; mean age 41.9 years, range 8 to 69 years) underwent SVC reconstruction for symptomatic nonmalignant disease. Causes included mediastinal fibrosis (n = 12), indwelling foreign bodies (n = 4), idiopathic thrombosis (n = 2), and antithrombin III deficiency (n = 1). Spiral saphenous vein graft (n = 14), polytetrafluoroethylene (n = 4), or human allograft (n = 1) was implanted. Results: No early death or pulmonary embolism occurred. Four early graft stenoses or thromboses (spiral saphenous vein graft, n = 2, polytetrafluoroethylene n = 2) required thrombectomy, with success in three. During a mean follow-up of 49.5 months (range, 4.7 to 137 months), 95 imaging studies were performed (average, five per patient; range, one to 10 studies). Venography detected mild or moderate graft stenosis in seven patients; two progressed to severe stenosis. Two additional grafts developed early into severe stenosis. Four of 19 grafts occluded during follow-up (two polytetrafluoroethylene, two spiral saphenous vein graft). Computed tomography failed to identify stenosis in two grafts, magnetic resonance imaging failed to confirm one stenosis and one graft occlusion, and duplex scanning was inconclusive on graft patency in 10 patients. Angioplasty was performed in all four patients with severe stenosis, with simultaneous placement of Wallstents in two. One of the Wallstents occluded at 9 months. Repeat percutaneous transluminal angioplasty was necessary in two patients, with placement of Palmaz stents in one. Only one graft occlusion and one severe graft stenosis occurred beyond I year. The primary, primary-assisted, and secondary patency rates were 61%, 78%, and 83% at I year and 53%, 70%, and 74% at 5 years, respectively. Conclusion: Long-term secondary patency rates justify SVC grafting for benign disease. Postoperative surveillance with contrast venography is indicated in the first year to detect graft problems. Endovascular techniques may salvage and improve the patency of SVC grafts.

AB - Purpose: Superior vena cava (svc) reconstructions are rarely performed; therefore the need for surveillance and the results of secondary interventions are unknown. Methods: During a 14-year period 19 patients (11 male, 8 female; mean age 41.9 years, range 8 to 69 years) underwent SVC reconstruction for symptomatic nonmalignant disease. Causes included mediastinal fibrosis (n = 12), indwelling foreign bodies (n = 4), idiopathic thrombosis (n = 2), and antithrombin III deficiency (n = 1). Spiral saphenous vein graft (n = 14), polytetrafluoroethylene (n = 4), or human allograft (n = 1) was implanted. Results: No early death or pulmonary embolism occurred. Four early graft stenoses or thromboses (spiral saphenous vein graft, n = 2, polytetrafluoroethylene n = 2) required thrombectomy, with success in three. During a mean follow-up of 49.5 months (range, 4.7 to 137 months), 95 imaging studies were performed (average, five per patient; range, one to 10 studies). Venography detected mild or moderate graft stenosis in seven patients; two progressed to severe stenosis. Two additional grafts developed early into severe stenosis. Four of 19 grafts occluded during follow-up (two polytetrafluoroethylene, two spiral saphenous vein graft). Computed tomography failed to identify stenosis in two grafts, magnetic resonance imaging failed to confirm one stenosis and one graft occlusion, and duplex scanning was inconclusive on graft patency in 10 patients. Angioplasty was performed in all four patients with severe stenosis, with simultaneous placement of Wallstents in two. One of the Wallstents occluded at 9 months. Repeat percutaneous transluminal angioplasty was necessary in two patients, with placement of Palmaz stents in one. Only one graft occlusion and one severe graft stenosis occurred beyond I year. The primary, primary-assisted, and secondary patency rates were 61%, 78%, and 83% at I year and 53%, 70%, and 74% at 5 years, respectively. Conclusion: Long-term secondary patency rates justify SVC grafting for benign disease. Postoperative surveillance with contrast venography is indicated in the first year to detect graft problems. Endovascular techniques may salvage and improve the patency of SVC grafts.

UR - http://www.scopus.com/inward/record.url?scp=0031882360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031882360&partnerID=8YFLogxK

U2 - 10.1016/S0741-5214(98)70359-3

DO - 10.1016/S0741-5214(98)70359-3

M3 - Article

C2 - 9510283

AN - SCOPUS:0031882360

VL - 27

SP - 287

EP - 301

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 2

ER -